Effect of Early Antiviral Therapy on Duration of Cough in Flu Patients
1 other identifier
observational
120
1 country
1
Brief Summary
This study mainly focused on the effect of early antiviral treatment on the duration of cough in influenza patients.investigators conducted an early investigation of patients with positive influenza virus and asked whether patients used antiviral drugs in the early stages. According to the use of drugs, patients were divided into oral oseltamivir group, oral lotus phlegm group and other groups, and investigators will collected Inspection information and medication status,during the treatment period of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2018
CompletedFirst Posted
Study publicly available on registry
August 7, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedAugust 7, 2018
July 1, 2018
1 year
July 4, 2018
August 4, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cough duration
Investigators will follow up every other week for follow-up calls or outpatients to ask about cough and medication, until the patient stops coughing, cough lasts from 1 day to 12 weeks, and cough time is greater than 12 weeks. Investigators should seriously exclude cough caused by other factors. No other factors are still included in the study, and the maximum time is no more than 6 months. If there are other factors causing cough, it will not be included in the study.
6 months
Study Arms (3)
Oral oseltamivir group
Patients with influenza virus positive and early oral oseltamivir capsules
Oral Lotus Capsules group
Patients with positive influenza virus and early oral administration of lotus extract capsules
other group
Influenza virus positive patients who were not treated with oral lotus capsule or oseltamivir capsules early
Eligibility Criteria
Flu patients who were diagnosed in our hospital from April 2018 to July 2019
You may qualify if:
- For patients with flu-free flu, cough for at least one week.
- In line with the flu etiological diagnostic criteria: According to the guidelines set by the National Health and Health Committee, the diagnosis is based on etiological screening methods or confirmed methods; ages 18 to 70 years.
- There are no influenza complications such as acute lower respiratory tract infection, tonsillitis, sinusitis, otitis media, myocarditis, etc.
- It is usually healthy and there are no chronic underlying diseases such as hypertension and diabetes.
- Treating with cough as the main symptom, the cough lasts for at least one week and the chest radiograph is normal.
- Signed informed consent.
You may not qualify if:
- Suspected flu patients who have not received the flu etiology test;
- There is a clear comorbid disease (combined with other sites of acute bacterial or viral infections);
- There is a clear cough caused by other reasons;
- With severe liver and kidney dysfunction;
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430060, China
Biospecimen
Blood samples Saliva samples Sputum samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Respiratory and Critical Care Medicine II
Study Record Dates
First Submitted
July 4, 2018
First Posted
August 7, 2018
Study Start
September 1, 2018
Primary Completion
September 1, 2019
Study Completion
December 1, 2019
Last Updated
August 7, 2018
Record last verified: 2018-07